Simplex Trading’s Lipocine LPCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,561
Closed -$37.6K 8755
2020
Q3
$37K Buy
+1,561
New +$41.5K ﹤0.01% 5891
2020
Q2
Sell
-6
Closed -$78 8014
2020
Q1
$0 Sell
6
-41
-87% -$324 ﹤0.01% 7964
2019
Q4
$0 Buy
+47
New +$1.2K ﹤0.01% 7655
2019
Q3
Sell
-226
Closed -$9.07K 7597
2019
Q2
$7K Buy
226
+201
+804% +$6.2K ﹤0.01% 6297
2019
Q1
$0 Buy
+25
New +$767 ﹤0.01% 7507
2018
Q4
Sell
-86
Closed -$2K 7453
2018
Q3
$2K Sell
86
-199
-70% -$4.89K ﹤0.01% 7081
2018
Q2
$6K Buy
285
+68
+31% +$1.62K ﹤0.01% 6622
2018
Q1
$5K Sell
217
-342
-61% -$9.52K ﹤0.01% 4651
2017
Q4
$32K Buy
+559
New +$34.8K ﹤0.01% 2855
2017
Q3
Sell
-3,686
Closed -$267K 6284
2017
Q2
$251K Buy
3,686
+3,628
+6,255% +$237K 0.01% 1056
2017
Q1
$3K Buy
+58
New +$3.76K ﹤0.01% 5017
2016
Q4
Sell
-485
Closed -$30.7K 6224
2016
Q3
$36K Buy
485
+165
+52% +$10.2K ﹤0.01% 2397
2016
Q2
$16K Sell
320
-17
-5% -$2.63K ﹤0.01% 3097
2016
Q1
$58K Buy
337
+325
+2,708% +$55.5K ﹤0.01% 1830
2015
Q4
$2K Buy
+12
New +$2.52K ﹤0.01% 4522

Other funds holding LPCN

Simplex Trading's LPCN Position: Q4 2020 in Review

Simplex Trading sold out of Lipocine (LPCN) in Q4 2020, closing a stake of 1,561 shares — an estimated $37.6K sold.

Simplex Trading first reported a position in LPCN in Q4 2015 and held it in 15 quarters. The position peaked at $251K in Q2 2017. 33 funds tracked by Wall St. Rank hold LPCN as of Q4 2020.

  • Simplex Trading reported no remaining Lipocine position as of Q4 2020 after selling out during the quarter.
  • Simplex Trading sold 1,561 Lipocine shares in Q4 2020, an estimated $37.6K.
  • Simplex Trading first reported a position in Lipocine in Q4 2015 and held it in 15 quarters.
  • Simplex Trading's Lipocine position peaked at $251K in Q2 2017.
  • 33 funds tracked by Wall St. Rank held Lipocine as of Q4 2020.

Based on Simplex Trading's 13F filing for Q4 2020, filed 2 Feb 2021.